March 27, 2014 bluebird bio, Inc. a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced that …
March 27, 2014 bluebird bio, Inc. a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced that …